Fig. 1

Kaplan-Meier survival analysis of hepatitis markers and HCC patients with dual hepatitis B and C. a, OS rates between high HBV-DNA level (≥1000 IU/mL, n = 9) group and low HBV-DNA level (<1000 IU/mL, n = 10); P = 0.003; b, RFS rates between high HBV-DNA level (≥1000 IU/mL, n = 9) group and low HBV-DNA level (<1000 IU/mL, n = 10); P = 0.152; c, OS rates between high HBsAg level (≥1000 IU/mL, n = 28) group and low HBsAg level (<1000 IU/mL, n = 6); P = 0.050; d, RFS rates between high HBsAg level (≥1000 IU/mL, n = 28) group and low HBsAg level (<1000 IU/mL, n = 6); P = 0.564; e, OS rates between HBeAg positive group (n = 6) and HBeAg negative group (n = 33); P = 0.000; f, RFS rates between HBeAg positive group (n = 6) and HBeAg negative group (n = 33); P = 0.068; g, OS rates between high HCV-Ab level (≥10.9 S/CO, n = 12) group and low HCV-Ab level (<10.9 S/CO, n = 8); P = 0.418; h, RFS rates between high HCV-Ab level (≥10.9 S/CO, n = 12) group and low HCV-Ab level (<10.9 S/CO, n = 8); P = 0.773